Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
SEDG gained 8% on the week, closing at $34.04 on Tuesday. That pop stands against a backdrop where short interest remains near one-fifth of the free float, analysts are reluctant to commit, and the next earnings print is less than a month away.
The positioning picture is layered. Short interest remains elevated at 19.5% of free float, roughly 11.6 million shares. That is, however, down from a peak above 14 million shares in mid-September, with the sharpest drop arriving around September 23. The borrow market has loosened noticeably: availability has recovered to 66%, up from its 52-week low of 20% hit on September 15. Cost to borrow has moved the other way, up around 21% over the past month to a still-modest 0.70%. The ORTEX short score sits at 70, firmly in bearish territory though broadly stable over the past two weeks. Options traders have turned more bullish than usual. The put/call ratio of 0.44 is running about 1.2 standard deviations below its 20-day average, the lowest in weeks. Taken together, the lending market is less charged than it was a month ago, but nearly a fifth of the float remains committed to the short side. This is not a crowded squeeze setup, but it is not a clean slate either.
The Street remains in a holding pattern, with most analysts clustering around neutral. Morgan Stanley maintained Equal-Weight with a $33 target following the August earnings miss. J.P. Morgan held Neutral but lifted its target to $44, and Mizuho raised its target to $40 while staying Neutral, both moves coming the day after the September earnings call. RBC raised its target to $30 from $24, also staying neutral, while Citigroup raised its Sell target to $30 from $25. The most recent action, Barclays lowering its Equal-Weight target by a dollar to $36 on October 7, barely moves the needle but signals no fresh conviction. UBS is the lone meaningful outlier, having upgraded to Buy with a $42 target in late August. GLJ Research remains at an outlier Sell with a $6.90 target, a level so distant from the current price and consensus that it reads as a structural bear position rather than a near-term call. The mean target is $38, roughly 12% above the current price. Factor scores flag the tension: EPS surprise ranks at zero, meaning the company has consistently missed, while 30-day EPS momentum ranks in the 72nd percentile, suggesting estimate revisions have been moving up more recently.
The bull and bear cases are clearly defined. Bulls point to $1.7 billion in firm safe-harbor contracts and $3.3 billion including optimizers as unusually strong revenue visibility, alongside the Nexis platform's potential to drive gross margins above 30% by 2029 and an emerging 800V DC-native solid-state transformer opportunity aimed at AI datacenters. Bears see U.S. residential permits down 31% year-on-year in the second quarter and Wood Mackenzie projecting a 13% decline in the U.S. commercial market in 2026. U.S. residential market share fell to 22.3% in Q1 2026 from 25% in Q4 2025. The recovery timeline remains genuinely uncertain, and the bear case adds a liquidity question mark around inventory monetization and 45X credit sales.
On the ownership side, BlackRock added roughly 1.1 million shares to reach 15.6% of the company, with that position current as of September 30. American Century added around 937,000 shares in its most recent disclosure. Harel Insurance, an Israeli insurer, added a substantial 2.3 million shares. On the other side, Menora Mivtachim trimmed 380,000 shares and Vanguard has reduced its disclosed position close to zero per a March 2026 filing, though as an indexed manager that may reflect ETF rebalancing rather than a directional view. The activist register carries no 13D filers. All 13D/G positions are as-last-disclosed around the 5% threshold and holders dropping below 5% may exit without a further filing.
Earnings history provides limited but pointed context. The August 5 print triggered a 33% single-day fall and a 34% five-day drop. The September 10 print, by contrast, moved the stock just 1.5% lower on the day, recovering 2.2% over the following five sessions. The next event is November 4. Whether the stock enters that date with short interest still near 20% of float, or whether the current unwind continues, is the primary variable to track between now and then.
See the live data behind this article on ORTEX.
Open SEDG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
